NCT03073031View on ClinicalTrials.gov

The Use of PatientReportedOutcomes (PRO)- CTCAE by Melanoma Patients Receiving Immunotherapy

NACompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

January 10, 2017

Primary Completion Date

November 1, 2019

Study Completion Date

November 1, 2019

Conditions
Adverse Effects
Interventions
DEVICE

Tablet: Samsung Galaxy Tab A

Trial Locations (1)

5000

Odense University Hospital, Odense

All Listed Sponsors
collaborator

REHPA, The Danish Knowledge Centre for Rehabilitation and Palliative Care

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Danish Cancer Society

OTHER

lead

Odense University Hospital

OTHER

NCT03073031 - The Use of PatientReportedOutcomes (PRO)- CTCAE by Melanoma Patients Receiving Immunotherapy | Biotech Hunter | Biotech Hunter